LifeTime Pharmaceuticals Report issue

For profit Phase 2
Founded: College Park MD United States (1992)
Status: Defunct (2005)

Organization Overview

First Clinical Trial
2000
NCT00006466
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2002

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

betathine (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lymphoma (Phase 2)

Multiple Myeloma (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Plasmacytoma (Phase 2)

Precancerous Conditions (Phase 2)

Waldenstrom Macroglobulinemia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 1